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The striate form of palmoplantar keratoderma is a
rare autosomal dominant disorder affecting palm
and sole skin. Genetic heterogeneity of striate pal-
moplantar keratoderma has been demonstrated with
pathogenic mutations in the desmosomal proteins
desmoplakin and desmoglein 1. We have studied a
four-generation family of British descent with striate
palmoplantar keratoderma. Ultrastructural studies
show that intermediate ®laments of suprabasal kera-
tinocytes are ®ner than those of the basal layer. In
addition, desmosome numbers are normal, but their
inner plaques and midline structures are attenuated.
Microsatellite markers were used to screen candidate
loci including the epidermal differentiation complex
on 1q, the desmoplakin locus on 6p, the type I and
II keratin gene clusters on chromosomes 12q and
17q, and the desmosomal cadherin gene cluster on
chromosome 18q. Signi®cant genetic linkage to
chromosome 12q was observed using marker
D12S368, with a maximum two-point lod score of
3.496 at a recombination fraction of 0. Direct
sequencing of the keratin 1 gene revealed a frame-
shift mutation in exon 9 that leads to the partial loss
of the glycine loop motif in the V2 domain and the
gain of a novel 70 amino acid peptide. Using expres-
sion studies we show that the V2 domain is essential
for normal function of keratin intermediate ®la-
ments. Key words: desmosomal disorders/genodermatosis/
intermediate ®laments/skin. J Invest Dermatol 118:838±
844, 2002
T
he inherited palmoplantar keratodermas are a clinically
varied group of skin disorders that primarily affect
palmoplantar epidermis. Striate palmoplantar kerato-
derma (SPPK; MIM 148700) (Siemens, 1929; El
Sayed and Bazex, 1993) is a rare autosomal dominant
skin disorder characterized clinically by linear and focal hyperkera-
tosis of the palms and soles (Grif®ths et al, 1998; Armstrong et al,
1999), although some phenotypic heterogeneity exists. Genetically,
SPPK is heterogeneous as linkage and subsequent mutations have
been found at two separate loci. Initially, Hennies et al (1995) found
linkage to chromosome 18q12 near the desmosomal cadherin gene
cluster, comprising the desmoglein and desmocollin genes. This
locus has subsequently been supported by the recent detection of
several mutations in the desmoglein 1 gene (Rickman et al, 1999;
Hunt et al, 2001). The ®rst study to demonstrate a pathogenic
mutation in this skin disorder (Armstrong et al, 1999), however,
initially showed linkage to the desmosomal plaque protein
desmoplakin at chromosome 6p21, and subsequent analysis
demonstrated a mutation in desmoplakin (Armstrong et al, 1999).
Indeed, this locus has been con®rmed by the detection of a second
mutation within the desmoplakin gene (Whittock et al, 1999). Both
desmoglein 1 and desmoplakin are components of speci®c cell
junctions named desmosomes that are involved in cell±cell
adhesion and cell communication (Garrod, 1993, 1996; Kouklis
et al, 1994; Green and Jones, 1996) and appear to cause SPPK by
haploinsuf®ciency of their respective proteins.
The keratins are a family of structurally related proteins that form
intermediate ®laments in the cytoplasm of epithelial cells (Quinlan
et al, 1994). They are expressed in pairs of type I (acidic), and type
II (basic) polypeptides in a tissue- and differentiation-speci®c
manner (Roop, 1995). Type I/II keratin pairs form heterodimers
through association of their a-helical rod domains, and further
polymerize to form the characteristic 10 nm ®laments (Parry et al,
1977). There are approximately 30 different keratin genes,
mutations in 18 of which cause a wide range of diseases affecting
skin, nails, hair, and mucosa (Corden and McLean, 1996; Irvine
and McLean, 1999; Ku et al, 2001). Pathogenic mutations in the
type I and II epidermal keratins occur within regions thought to be
involved in keratin intermediate ®lament assembly, namely the H1
domain, the helix initiation motif, the L12 linker region, and the
helix termination motif (Irvine and McLean, 1999). Mutations
in these regions of the suprabasally expressed keratins K1 and
K10 underlie bullous congenital ichthyosiform erythroderma/
epidermolytic hyperkeratosis (MIM 113800). A missense mutation
outside the ``hot-spots'' has been identi®ed in K1, however, that
may affect intermolecular connections rather than ®lament
assembly. In a case of diffuse nonepidermolytic palmoplantar
keratoderma a mutation within the V1 domain of K1 (K74I) has
been documented (Kimonis et al, 1994). Ultrastructural studies
showed a normal tono®lament pattern, although morphologic
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inspection showed alterations in the tono®lament network organ-
ization adjacent to the corni®ed cell envelope. Further studies
demonstrated that this lysine residue is critical for the formation of
intermolecular connections between tono®laments and proteins of
desmosomes and the corni®ed cell envelope via transglutaminases
(Kouklis et al, 1994; Candi et al, 1998).
In this study, we investigated a four-generation kindred with
SPPK and showed that it is due to a novel frameshift mutation
within the V2 domain of K1. We also demonstrate using in vitro
transfections that the clinical phenotype in this family is probably a
consequence of loss of glycine repeats rather than gain of a novel
carboxy terminus.
MATERIALS AND METHODS
Clinical ®ndings Members of the kindred were examined by the
following authors: RM, WAG, RAE, and JAM. Following informed
consent, blood samples were available from nine affected and nine
unaffected family members. Genomic DNA was extracted from
peripheral blood lymphocytes using standard methods.
Electron microscopy Skin specimens were ®xed in half-strength
Karnovsky ®xative (containing 2% formaldehyde and 2.5% glutar-
aldehyde in 0.04 M cacodylate buffer), followed by further ®xation in
1.3% osmium tetroxide. The samples were then processed with standard
transmission electron microscopy techniques and mounted in Epon resin
(Tidman and Eady, 1985). For electron microscope examination,
ultrathin sections were stained with uranyl acetate and lead citrate and
observed in a JEOL 100CX transmission electron microscope.
Genotyping and linkage analysis Microsatellite markers were chosen
from the GeÂneÂthon and Marsh®eld genetic linkage maps (Dib et al, 1996;
Broman et al, 1998). Markers D1S305 and D1S498 were used for the
epidermal differentiation complex on 1q (Marenholz et al, 1996), markers
DES.MIC1 and DES.MIC3 were used for the desmoplakin gene on 6p
(Norgett et al, 2000), markers D12S90 and D12S96 were used for the
type II keratin cluster on 12q, markers D17S1787 and D17S1868 were
used for the type I keratin gene cluster on 17q, and markers D18S463
and D18S536 were used for the desmosomal cadherin gene cluster on
18q. Polymerase chain reactions (PCR) were performed in 7.5 ml
containing 100 ng of template DNA, 1 3 GeneAmp PCR buffer II
(ABI, Foster City), 330 nM of each primer, 250 mM dNTPs, 2.5 mM
MgCl2, and 0.30 units of Amplitaq Gold DNA polymerase (ABI) in a
Touchdown ThermoCycler (Hybaid, Ashford, U.K.). One of the two
primers was 5¢ labeled with ¯uorescent FAM, HEX, or NED dyes
(ABI). Microsatellite DNA marker analysis was performed on an ABI377
automated DNA sequencer running Genescan and Genotyper software
(ABI). Two-point lod scores were computed using Cyrillic version 2.1.3
(Cherwell Scienti®c Publishers, Oxford, U.K.) running the MLINK
algorithm of LINKAGE version 5.1. The mutant allele frequency was
assumed to be 0.001 with 100% penetrance. Allele frequencies were
assumed to be equal in the population.
Mutation detection Total RNA was isolated from skin biopsy or
cultured keratinocytes using the acid guanidinium thiocyanate±phenol±
chloroform method (Chomczynski and Sacchi, 1987) and subjected to
random hexamer primed cDNA synthesis. Exons 1±9 of the human K1
gene were directly ampli®ed from genomic DNA as previously described
(Whittock et al, 2000), except that the reverse primer for exon 9 was
replaced with primer K1 e9R3¢ 5¢-GCA AGG AGC TGT CCA CAC-
3¢ (antisense). For PCR, 200 ng of patient or control genomic DNA was
added to a premix containing PCR buffer [67 mM Tris±HCl pH 8.8,
16.6 mM (NH4)2SO4, 1.5 mM MgCl2, 0.17 mg per ml bovine serum
albumin (Sigma, Poole, U.K.), and 10 mM 2-mercaptoethanol], 10 nmol
of each dNTP, and 20 pmol of each primer in a total volume of 50 ml.
After an initial denaturation at 95°C for 2 min, 2.5 units of Taq
polymerase (Promega, Madison, WI) were added followed by 35 cycles
of 95°C for 10 s, annealing temperature for 10 s, 72°C for 30 s, with a
®nal incubation of 72°C for 5 min. The PCR products were examined
by 1% agarose gel electrophoresis, puri®ed using spin columns (Qiagen,
Crawley, U.K.), and directly sequenced using Big Dye terminators on an
ABI 3100 genetic analyzer (ABI).
Con®rmation of mutation To study the inheritance pattern of the
mutation within the family and unrelated normal controls, ¯uorescent
PCR was performed using primers K1 e9F (Whittock et al, 2000) (sense)
and K1 e9R5¢ 5¢-FAM-CCT CCA GAG CCA TAG CTG-3¢
(antisense) to amplify a 251 bp fragment. Fragment analysis was
performed on an ABI 377 automated DNA sequencer running Genescan
and Genotyper software as described above. To determine whether the
mutant allele was expressed at the transcript level, mRNA was isolated
from cultured cells and single stranded cDNA was synthesized as above.
Primers K1 e8/9 5¢-GTG AGT GTG TCT GTG AGC-3¢ (sense) and
K1 e9R5¢ 5¢-CCT CCA GAG CCA TAG CTG-3¢ (antisense) were
Figure 1. Pedigree of the family with
autosomal dominant SPPK analyzed in this
study. There are 14 affected individuals and 20
unaffected individuals. The proband is indicated
by the arrow. Asterisks indicate individuals taking
part in this study.
Figure 2. Clinical appearance of the SPPK
family. (a) The affected proband and his two sons
show focal keratoderma on the palms and some
linear hyperkeratosis along the ®ngers. (b) The
proband shows focal hyperkeratosis on the soles.
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used to amplify a 209 bp fragment using the above conditions. The
PCR products were examined by 1% agarose gel electrophoresis,
puri®ed using spin columns, and directly sequenced as above.
Site-directed mutagenesis and expression studies To determine
whether the clinical phenotype was due to the loss of the V2 domain or
the gain of a novel peptide, we performed site-directed mutagenesis on a
K1-GFP cDNA construct (gift of Sarah Hatsell and David Kelsell,
Center for Cutaneous Research, St. Bartholomew's and The Royal
London School of Medicine and Dentistry, Queen Mary and West®eld
College, London) using the QuikChange Kit (Stratagene) according to
the manufacturer's instructions. The K1-GFP construct was made by
inserting the K1 cDNA between the EcoR1 and Pst1 sites of the vector
pEGFP-C3 (Clontech, Palo Alto, CA). Primers used for the 1628delG
mutation described in this study were 5¢-GCT ATG GTT CTG GAG
TGG CGG CGG C-3¢ (sense), and 5¢-GCC GCC GCC ACT CCA
GAA CCA TAG C-3¢ (antisense). Primers used to insert a stop codon at
the start of the second glycine repeat (1624 G®T) were 5¢-GCT ATG
GTT CTT GAG GTG GCG GCG GC-3¢ (sense), and 5¢-GCC GCC
GCC ACC TCA AGA ACC ATA GC-3¢ (antisense). Primers used to
insert a stop codon at the end of the H2 domain (1540 G®T) were 5¢-
CAC CAC CAT CAG TTG AGG TGG CAG CC-3¢ (sense), and 5¢-
GGC TGC CAC CTC AAC TGA TGG TGG TG-3¢ (antisense).
Primers used to replicate the V2 domain mutation described by Sprecher
(Sprecher et al, 2001) (1609 GG®A) were 5¢-GGC TCC GGA GGT
ATA GCT ATG GTT CTG G-3¢ (sense), and 5¢-CCA GAA CCA
TAG CTA TAC CTC CGG AGC C-3¢ (antisense).
K1-GFP transfections HaCaT cells (spontaneous human keratinocyte
cell line) were grown on 13 mm round coverslips in Dulbecco's
modi®ed Eagle's medium (Sigma) containing 10% fetal bovine serum,
100 U per ml penicillin, and 100 mg per ml streptomycin until
approximately 50% con¯uent. The cells were transfected with K1-GFP
constructs using Fugene 6 (Roche Molecular Biochemicals, Lewes,
U.K.) according to the manufacturer's instructions. Cells were ®xed 24 h
after transfection in 3% paraformaldehyde and permeabilized with 0.2%
Triton X-100. Cells were stained with 4,6-diamidino-2-phenylindole
(1 mg per ml; Sigma) for 5 min at room temperature and mounted in
hydromount containing 2.5% 1,4-diazabicyclo[2.2.2]octane (Sigma).
Cells were visualized using an Olympus BX50 microscope with
MacProbe v 4.0.1 software (Perceptive Scienti®c Instruments, League
City, TX).
RESULTS
Clinical A single four-generation family of British origin with 14
individuals affected with PPK was studied (Fig 1). The inheritance
pattern of PPK in the family was consistent with an autosomal
dominant mode of inheritance, exhibiting male-to-male trans-
mission. Affected individuals presented during early childhood with
a phenotype that exhibits SPPK on the palms and more diffuse
changes on the soles (Fig 2). There was no involvement of
nonpalmoplantar skin, however, and both hair and nails were
normal.
Transmission electron microscopy Ultrastructural studies on
lesional skin showed that the stratum corneum and nucleated
epidermal layers were thickened. Keratin intermediate ®laments
within basal keratinocytes appeared normal, in contrast to those of
the spinous layers, which appeared to be much less electron dense
and possibly shorter than normal, although the cell shape and size
appeared normal (Fig 3). Ultrastructural studies on nonlesional skin
also demonstrated less electron dense keratin ®laments in the
spinous layer (not shown). Desmosomes appeared to be present in
normal numbers, but their outer plaques (where the tono®laments
insert) and midline structures appeared attenuated.
Figure 3. Electron microscopy analysis of palmoplantar
epidermis. Electron microscopy reveals normal keratin intermediate
®laments in the basal keratinocytes (B), whereas those of the suprabasal
keratinocytes (SB) are less electron dense. Arrow indicates the basement
membrane. Scale bar: 2 mm.
Table I. SPPK family: two-point lod scores with 12q markersa
Marker Distance
Zmax
q = 0 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50
D12S345 53.09 ±‘ 1.919 1.938 1.817 1.627 1.390 1.117 0.818 0.509 0.221 0.000
D12S1663 56.38 ±‘ 1.743 1.763 1.643 1.457 1.228 0.971 0.699 0.432 0.194 0.000
D12S85 61.34 ±‘ 1.744 1.787 1.690 1.526 1.316 1.070 0.797 0.509 0.232 0.000
D12S1701 62.54 1.178 1.090 0.998 0.902 0.801 0.693 0.577 0.451 0.315 0.165 0.000
D12S368 66.03 3.496 3.208 2.905 2.584 2.245 1.885 1.505 1.106 0.701 0.318 0.000
D12S96 68.16 1.454 1.403 1.310 1.187 1.039 0.871 0.685 0.487 0.290 0.116 0.000
D12S90 71.61 1.780 1.581 1.373 1.158 0.936 0.710 0.489 0.291 0.141 0.049 0.000
D12S83 75.17 3.311 3.044 2.762 2.464 2.149 1.814 1.459 1.086 0.703 0.331 0.000
D12S313 79.93 2.758 2.493 2.214 1.921 1.613 1.291 0.960 0.634 0.340 0.119 0.000
D12S326 86.40 ±‘ 0.269 0.436 0.471 0.448 0.390 0.309 0.216 0.122 0.044 0.000
D12S351 95.56 ±‘ 1.080 1.175 1.134 1.031 0.886 0.712 0.517 0.314 0.131 0.000
aSex-averaged genetic distances in centiMorgans (cM) from the Marsh®eld Genetic Map.
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SPPK is linked to 12q DNA was prepared from 18 family
members, including nine affected individuals, and tested for genetic
linkage using a panel of microsatellite markers located near
candidate genes involved in the structure and/or development of
epithelial tissues. Markers located on chromosomes 1q, 6p, 17q,
and 18q were excluded for linkage to the disease, thereby indicating
that the gene for SPPK in this study was not located in the
epidermal differentiation complex, the desmoplakin locus, the type
I keratin gene cluster, or the desmosomal cadherin gene cluster,
respectively (data not shown). In contrast, signi®cant linkage was
seen with a number of markers located in the vicinity of the type II
keratin gene cluster on chromosome 12q, as shown in Table I.
Maximum two-point lod scores of 3.496 and 3.311 at q = 0 were
obtained for the markers D12S368 and D12S83, respectively
(Table I). Visible recombination events in the family excluded the
PPK gene from the region centromeric to D12S85 and telomeric to
D12S326. Hence, the genetic defect in this family is located
between the microsatellite markers D12S85 and D12S326, which
encompass the type II keratin gene cluster (http://genome.
ucsc.edu).
Sequence analysis Of the type II keratin genes, those expressed
in palmoplantar skin were considered as candidates. Due to the fact
that the keratin intermediate ®laments of the spinous layer appeared
abnormal, however, we decided to concentrate initially on the K1
gene KRT1. Genomic DNA from one affected and one unrelated
individual was used to PCR amplify each of the nine exons of
KRT1 using conditions previously described, followed by direct
sequencing. Sequence analysis of exons 1±8 revealed no potential
pathogenic mutations; however, analysis of exon 9 revealed a
deletion of a G nucleotide at position 1628 (1628delG with
reference to GenBank accession no. NM_006121) (Fig 4). Speci®c
¯uorescent PCR demonstrated that the deletion segregated with
the disease in the family studied, but was not present in 100
unrelated ethnically matched control chromosomes. In addition,
the ¯uorescent PCR encompassed the 21 bp deletion
polymorphism that results in the deletion of a complete glycine
loop motif as described by Korge et al (1992a). Analysis
demonstrated that although some affected family members had
also inherited the 21 bp deletion polymorphism it was not on the
same allele as the 1628delG mutation and therefore did not
cosegregate with the disease-causing mutation. Screening of
unaffected normal controls for the 21 bp polymorphism yielded a
polymorphism information content (PIC) of 0.39, thus indicating
its usefulness for linkage analysis.
Effect of the mutation on the K1 protein The mutation
1628delG is predicted to cause a frameshift with a subsequent
premature stop codon to be inserted 70 amino acids downstream of
the deletion (Fig 5). This region of K1 has been postulated to
anchor intermediate ®laments to the corni®ed cell envelope. To
determine whether the mutant transcript had been degraded we
used reverse transcription PCR (RT-PCR) on mRNA extracted
from patient cultured keratinocytes. Direct sequencing of the RT-
PCR product demonstrated both mutant and wild-type alleles
(Fig 4), therefore indicating that although the mutant allele
contained a premature termination codon it had not been
signi®cantly degraded by nonsense mediated mRNA decay.
K1-GFP expression studies To determine whether the
pathology of the disease is due to the loss of glycine loops of K1
or the gain of a novel peptide, several K1-GFP constructs were
made using site-directed mutagenesis. The mutation 1628delG
described in this study, as well as 1609 GG®A recently
characterized in a case described as ichthyosis hystrix Curth±
Macklin (Sprecher et al, 2001), 1540 G®T to create a stop codon
after the H2 rod domain, and 1624 G®T to create a stop codon
within the fourth glycine loop motif were constructed (Fig 6).
These constructs were transfected into HaCaT cells that already
possess suprabasal K1/10 intermediate ®laments to determine
whether their expression disrupted ®lament formation or
localization. GFP vector control alone demonstrated a widespread
diffuse distribution (not shown). The wild-type K1 showed a
normal ®lamentous distribution forming desmosomal contacts
between cells (Fig 7a). Although the four mutant constructs
showed some cytoplasmic ®lament staining that appeared less
Figure 4. Characterization of the K1 mutation. Nucleotide
sequencing of the proband DNA reveals the heterozygous deletion
1628delG (indicated by the arrow) in exon 9 of KRT1. Nucleotide
sequencing of the proband cDNA also reveals heterozygosity at this
nucleotide position, thus demonstrating that the mutant allele is not
degraded via the nonsense mediated mRNA decay pathway.
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dense, however, most of the staining was in a nuclear localization in
each case (Fig 7b±e). It could therefore be concluded that the
nuclear localization observed is due to the loss of the wild-type V2
and not the gain of the novel peptide seen in the two frameshift
mutants (1609 GG®A and 1628delG).
DISCUSSION
Here we report a kindred affected with SPPK that is caused by a
frameshift mutation within the V2 domain of K1, resulting in a
novel apolar a-helical forming peptide. The V2 domains of the
terminally differentiating epidermal keratins K1 and K10 are
unusually glycine rich in comparison with other keratins. These
glycine-rich sequences follow the form X(Y)n where X is usually
an aromatic or aliphatic residue, Y is usually glycine and n is highly
variable between 1 and 35 residues. These glycine-rich sequences
are predicted to form loops by the grouping of intervening aliphatic
amino acids (Steinert et al, 1991). Previous studies have shown that
glycine loops are highly insoluble and their presence may confer
¯exibility within the cell (Steinert, 1993). In basal cells there are
reduced numbers of loops in K5 and K14 indicating that ¯exibility
within the basal cells may be tolerated. The glycine loop motif is
also very prominent in loricrin, a protein that constitutes approxi-
mately 70% of the corni®ed cell envelope of terminally differen-
tiated epidermis (Hohl et al, 1991; Yoneda et al, 1992b). Along with
the loops formed by K1 and K10 it has been proposed that the
cytoplasmic surface of the corni®ed cell envelope is abundant with
glycine loops. A ``velcro'' hypothesis suggests that the glycine loops
of the keratins associate with those of loricrin by weak hydrophobic
and hydrogen bonding interactions that stabilize and integrate the
cell envelope with the keratin intermediate ®lament network
(Steinert et al, 1991). Therefore, based on this ``velcro'' hypothesis,
the loss of or a signi®cant reduction in the number of glycine loops
of either K1 or K10 would be expected to weaken the cell
envelope/keratin ®lament interface and lead to diminished ¯exi-
bility of the terminally differentiating cells that under mechanical
stress would lead to cell damage. Natural polymorphisms in the
number of V2 glycine loops have been determined for both K1 and
K10 (Korge et al, 1992a; 1992b; Mischke, 1993), as well as loricrin
(Yoneda et al, 1992a). These alterations either change the size of the
glycine loop or delete whole loops along with an associated
aromatic residue. The two K1 V2 polymorphisms determined to
date comprise either nine or ten glycine loops. Of the 11 K10
polymorphisms reported to date the number of glycine loops range
from seven to nine loops. In the case where a deletion has led to
only six loops, a substitution has led to the insertion of a new
aromatic residue thus increasing the number of loops to seven. It
could be postulated that further reduction in the number of glycine
loops compromises the formation of essential links between K1 and
K10 and the cell envelope, is deleterious to the cell, and has been
eliminated by natural selection.
In this study, the frameshift mutation occurs within the fourth
predicted glycine loop; thus only the ®rst three are complete. This
mutation is very similar to that recently described in a family
diagnosed as autosomal dominant ichthyosis hystrix Curth±Macklin
(Sprecher et al, 2001) in which a frameshift mutation occurs within
the third glycine loop. As well as the reduction in the number of
Figure 5. Position and effect of the 1628delG
mutation. (a) Position of the frameshift mutation
within the V2 domain of K1. (b) Comparison of
the amino acid sequence of the V2 domain of K1
for wild-type, 1628delG, and 1609GG®A
(Sprecher et al, 2001). The predicted glycine loop
motifs are numbered and the aromatic/aliphatic
amino acids are underlined. The novel C-terminal
amino acid sequences are in bold.
Figure 6. Site-directed mutagenesis constructs. (a) Wild-type; (b)
1628delG; (c) 1609 GG®A; (d) 1540 G®T; (e) 1624 G®T.
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glycine loops, the mutation characterized in this study and that of
Sprecher et al (2001) results in a novel peptide at the carboxy
terminus of the K1 protein. The latter mutation results in the same
novel peptide with an additional six amino acid residues at its start;
however, molecular modeling shows that this six amino acid
residue stretch probably acts as a linker between the glycine loop
motif and the predicted a-helical structure of the novel apolar
peptide (Sprecher et al, 2001). In addition, both K1 V2 domain
mutants have their E2 domains missing. Therefore, the only
signi®cant difference in molecular terms between the severe
mutilating form of ichtyosis hystrix Curth±Macklin (Sprecher
et al, 2001) and the milder SPPK is the number of glycine loops
present.
Site-directed mutagenesis and K1-GFP transfection studies
demonstrated that the mutant keratin is partially nuclear in its
localization although some intermediate ®laments are formed. This
partial nuclear localization of mutant K1, however, appears to be
due to the loss of the V2 domain rather than the gain of a novel
carboxy terminal peptide, as constructs lacking the entire V2
domain are also partially nuclear. Analysis of the novel peptide
sequence, however, reveals no potential nuclear localization signal
(NLS). Comparisons can be made with the localization of mutant
loricrin. All loricrin mutations detected to date in both the
ichthyotic variant of Vohwinkel syndrome and progressive sym-
metric erythrokeratoderma consist of one base-pair insertion
(Maestrini et al, 1996; Ishida-Yamamoto et al, 1997; Korge et al,
1997; Armstrong et al, 1998; Takahashi et al, 1999). This results in
the replacement of the glycine, glutamine, and lysine rich wild-type
protein with a basic carboxy terminal domain consisting mainly of
leucine, tryptophan, and arginine residues. Mutant loricrin is also
nuclear but in this case it is due to a bipartite NLS within the novel
mutant peptide (Korge et al, 1997; Ishida-Yamamoto et al, 2000;
Suga et al, 2000). Therefore, it can be concluded that the V2
domain is necessary for the maintenance of K1 within the
cytoplasm.
Of interest, a one base-pair deletion or two base-pair insertion in
loricrin would result in an alanine-rich peptide as characterized in
the two K1 V2 frameshift mutations. It is interesting to consider
why no patients have been characterized with these mutations.
Would they result in a different phenotype, would they be
embryonically lethal, or would they not present with an abnormal
phenotype at all? Unfortunately, the mouse studies conducted on
the loricrin one base-pair insertions did not answer this question
(Suga et al, 2000). The converse can also be said of K1 V2
mutations. Although only two mutations have been studied to date,
they both result in a one base-pair deletion. It is possible that a one
base-pair insertion would create an NLS and possibly a different
phenotype.
Whether the difference between two or three complete glycine
loops could infer such a contrast in phenotype is somewhat
questionable and there may be other predisposing factors in the
development of a severe phenotype. Assuming that the ``velcro''
hypothesis is correct then the number of glycine loops in K10 and
loricrin may be signi®cant when those in K1 are reduced.
Unfortunately, the study by Sprecher et al (2001) did not refer to
the number of glycine loops in loricrin or K10, and comparisons
must be made to ascertain the true underlying cause in the
difference between these two phenotypes.
In conclusion, this study shows that SPPK can be caused by
mutations in a type II epidermal keratin, namely the epidermal
differentiation-speci®c K1. This now increases the number of loci
for SPPK to three. The use of transmission electron microscopy
could be used to determine the nature of the desmosome/
tono®lament morphology, thus providing an insight into the gene/
protein implicated in an individual case. When samples are available
from family members with SPPK genetic linkage must encompass
markers for desmoplakin on 6p, the type II keratins on 12q, and
desmoglein 1 on 18q, before commencing mutation screening. It
can be concluded that mutations within the V2 domains of other
epidermal keratins have the potential to underlie a whole range of
keratodermas without affecting keratin ®lament assembly. In
conclusion, the ultrastructural ®ndings described here are unique
in SPPK, and although the molecular defect is very similar to that
recently reported in ichthyosis hystrix, the changes in the keratin
intermediate ®laments are very different.
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